Perceptive Xontogeny Venture Fund, LP, Director at Astria Therapeutics, Inc. (ATXS), bought 4,962,700 shares at $12.09 ($60.0M) on 2024-02-01, disclosed to the SEC on 2024-02-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.09 | 2,481,350 | $30.0M | 50.0% |
| 2 | $12.09 | 2,481,350 | $30.0M | 50.0% |
| Total | $12.09 avg | 4,962,700 | $60.0M | 100% |